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A B S T R A C T
Dogs with spontaneous disorders of glucocorticoid production often have marked disturbances in calcium
homeostasis. For example, hypercalcaemia is frequently observed in dogs with hypoadrenocorticism
and secondary hyperparathyroidism is a common feature of canine hyperadrenocorticism. The mecha-
nism(s) by which glucocorticoidsmodulate calcium homeostasis in dogs remains ill-deﬁned. The hypothesis
of this study is that a marked increase in serum cortisol concentrations would lead to an immediate neg-
ative calcium balance state which would drive a compensatory increase in parathyroid hormone (PTH)
concentrations. This hypothesis was investigated by measuring serum cortisol and plasma PTH concen-
tration in 19 dogs before and after administration of adrenocorticotrophic (ACTH) hormone. Post ACTH
administration, there was a signiﬁcant increase in serum cortisol, but not PTH, concentrations. The results
of this study do not support the hypothesis that an increase in endogenous glucocorticoids inﬂuences
calcium balance suﬃciently to cause an immediate, compensatory increase in parathyroid hormone
concentration.
© 2014 Elsevier Ltd. All rights reserved.
Dogs with spontaneous disorders of glucocorticoid production
often have markedly disturbed calcium homeostasis. For example,
approximately 30% of dogs with primary hypoadrenocorticism, a
condition in which dogs have deﬁcient production and secretion of
glucocorticoids, present with hypercalcaemia (Adamantos and Boag,
2008; Peterson et al., 1996). Despite hypercalcaemia being a feature
of hypoadrenocorticism, the pathogenesis of this complication re-
mains poorly understood. A recent study of calcium homeostasis
in hypercalcaemic dogs with hypoadrenocorticism found that the
concentrations of parathyroid hormone (PTH), parathyroid hormone
related protein (PTHrp) and 1,25 dihydroxyvitamin D (1,25(OH)2D),
which can all increase serum calcium concentrations, were within
their respective reference ranges (Gow et al., 2009). A range of other
explanations have been proposed to explain the development of hy-
percalcaemia in the absence of glucocorticoids including decreased
glomerular ﬁltration of calcium and/or increased tubular calcium
reabsorption, excessive intestinal absorption of calcium and
increased bone resorption (Hahn et al., 1981; Rath and Reddi, 1979;
Walker and Davies, 1981; Walser et al., 1963).
Conversely, dogswith hyperadrenocorticism,where either an ACTH
production pituitary tumour or an adrenal tumour results in the ex-
cessive production of glucocorticoids, frequently have increased plasma
concentrations of PTH (Ramsey et al., 2005). Again, the pathophysiol-
ogy of this condition is poorly understood although a negative calcium
balance, direct stimulation of PTH secretion by cortisol, altered vitamin
D metabolism and increased phosphate balance have been postu-
lated to be important (Ramsey et al., 2005).
A plausible explanation for the alterations in calcium homeostasis
which occur in glucocorticoid disorders in dogs is that an absence of
glucocorticoids leads toan increasedcalciumbalancewhereasanexcess
leads toareducedcalciumbalance throughalteredgastrointestinaland/
orrenalhandlingof calcium.Thishypothesiswouldleadtotheprediction
thatdogswithanexcessofglucocorticoidswouldhaveareducedcalcium
balancewhichwould cause PTH concentrations to increase in order to
maintain calcium within the reference range whereas an absence of
glucocorticoidswould cause an increased calciumbalance resulting in
aPTHconcentrationwithinor below the reference range. This hypoth-
esis is compatiblewith theclinicalobservations thatPTHconcentrations
are frequently increased in dogs with hyperadrenocorticism and are
withinorbelowthe reference range indogswithhypoadrenocorticism
(Gow et al., 2009; Ramsey et al., 2005).
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In order to examine this hypothesis further, we measured PTH
concentrations before and after an ACTH stimulation test in dogs
undergoing adrenal function testing assessed as part of their stan-
dard clinical assessment, where we were interested in assessing
adrenal function further. Administration of ACTH typically results
in a signiﬁcant increase in cortisol in dogs with normal adrenal
function (Cohen and Feldman, 2012). We predicted that PTH, which
has a short half-life and can rapidly increase in response to phys-
ical exertion and quickly decreases follow parathyroidectomy
(Graham et al., 2012; Tsai et al., 1997), would increase in response
to the increased serum concentrations of cortisol.
Consecutive cases of dogs which were undergoing an ACTH
stimulation test as part of their standard clinical evaluation were
considered eligible for inclusion in the study. A serum and EDTA
plasma sample was collected prior to the intravenous administra-
tion of 0.125 mg i.v. of tetracosactide acetate (Nycomed Austria
GmbH, St-Peter-Strasse 25, A-4020 Linz, Austria) (dogs up to 5 kg)
or 0.25 mg i.v. of tetracosactide acetate (dogs >5 kg). Serum corti-
sol was measured immediately and 1 hour post the intravenous
administration of tetracosactide acetate by immulite immunoas-
say (Siemens Medical Solutions Diagnostics, Healthcare Sector,
Henkestrasse 127, D-91052 Erlangen, Germany) (reference range
20–230 nmol/l). Serum total calciumwas measured using a ILab650
biochemistry analyser, Diamond Diagnostics, USA. Samples for para-
thyroid hormone measurement were collected by immediately
separating and freezing plasma from blood collected into EDTA tubes.
The samples were stored at −70 °C before sending to laboratory
for analysis on dry ice. The plasma PTH concentrations were mea-
sured using a canine intact PTH ELISA (Immutopics International,
931 Calle Negocio, Suite G, San Clemente, California, USA). Pre- and
post-ACTH cortisol and PTH concentrations were compared using
a paired Wilcoxon test. Signiﬁcance was set at p < 0.05. The study
was approved by the University of Edinburgh Veterinary Ethics
Research Committee.
Nineteen dogs were included in the study. Fourteen breeds of
dog were represented. There were 3 neutered males, 5 intact males
and 10 neutered females. The median age of the dogs was 102
months (range 25–157 months). Ten dogs had a ﬁnal diagnosis of
inﬂammatory bowel disease. One was diagnosed with hyperadre-
nocorticism, 4 with chronic hepatitis, 2 with pyelonephritis, 1 with
diabetes insipidus and 1 with chronic renal disease. Sixteen dogs
had serum calcium values within reference range (2.3–3 mmol/l)
with a medium calcium value of 2.4 mmol/l and a range of
1.74mmol/l–2.96mmol/l. Two dogs hadmild hypocalcaemia. Serum
cortisol concentrations increased following ACTH administration
(p < 0.0001, Fig. 1, median pre 80.3 nmol/l, median post 459.5 nmol/
l). The mean plasma PTH concentrations did not increase following
ACTH administration (p = 0.48, Fig. 2, median pre 84 pg/ml, median
post 84 pg/ml; range pre <10.0 pg/ml–502 pg/ml and range post
<10.0 pg/ml–530 pg/ml) (reference range 20–65 pg/ml).
The central ﬁnding of this study is that ACTH signiﬁcantly in-
creases cortisol in dogs but has no impact on short term PTH
concentrations. This observation is consistent with our previous work
that found that PTH concentrations did not increase in dogs with
atopic dermatitis following a 7 week course of a therapeutically ef-
fective dose of prednisolone (Kovalik et al., 2012). Together, these
ﬁndings argue against the hypothesis that glucocorticoids cause a
negative calcium balance in dogs since a signiﬁcant increase in renal
loss of calcium or a decrease in intestinal absorption of calcium
would trigger an increase in PTH concentrations. However, our
current study, which only longitudinally tracked PTH concentra-
tions for 1 hour post ACTH administration, does not exclude the
possibility that PTH concentrations may increase at later timepoints.
The ﬁndings in this study are also consistent with studies in humans
which found that PTH concentrations did not increase following glu-
cocorticoid therapy (Hahn et al., 1981; Prummel et al., 1991; Seeman
et al., 1980).
The lack of increase in PTH in response to a short term in-
crease in cortisol or to a therapeutically effective dose of prednisolone
contrasts with the ﬁnding that PTH is typically increased in dogs
with hyperadrenocorticism (Ramsey et al., 2005). The reason(s) for
this difference are unclear but may relate to a greater magnitude
and duration of glucocorticoid excess which typically occurs in dogs
with hyperadrenocorticism.
The ﬁndings of this study also contrast with reports in humans
administered ACTH for infantile spasms, which has been associ-
ated with nephrocalcinosis and osteoporosis side effects (Katzir et al.,
1992; Riikonen et al., 1986). Chronic administration of ACTH can
result in hypocalcaemia, an increase in urinary excretion of calcium
and an increase in serum parathyroid hormone (Riikonen et al.,
1986). The differences between our study and the ﬁndings in humans
may relate to the dose and duration of ACTH administration. The
failure of an increase in glucocorticoids to cause an immediate in-
crease in plasma PTH concentration in dogs also differs from the
ex-vivo observation that cortisol can increase PTH secretion from
parathyroid tissue (Au, 1976). However, the measurement of PTH
on one occasion post ACTH administration may fail to detect glu-
cocorticoid induced alterations in the pulsatile secretion dynamics
of PTH which have been reported to occur in short term treat-
ment with glucocorticoids (Bonadonna et al., 2005).
The ﬁndings of this study and our earlier work do not support
the concept that glucocorticoids modulate calcium balance in dogs.
Additional studies examining PTH concentrations at several
timepoints post ACTH administration would be informative sinceFig. 1. Serum cortisol concentrations pre and post ACTH administration.
Fig. 2. Plasma parathyroid hormone concentrations pre and post ACTH administration.
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PTH concentrations may increase at later timepoints. Studies ex-
amining urinary fractional excretion of calcium in dogs with either
hypoadrenocorticism or hyperadrenocorticism pre- and post-
treatment would be helpful in further examining whether
glucocorticoids induce a negative calcium balance in dogs with spon-
taneous disorders of glucocorticoidmetabolism. All dogs in this study
had an underlying disease and underwent an ACTH stimulation
as part of their standard diagnostic evaluation. Consequently, the
ﬁndings in this study cannot be directly extrapolated to healthy dogs.
Finally, additional studies examining whether glucocorticoids mod-
ulate gastrointestinal absorption of calcium would be valuable.
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